NUVB

SEC filing NUVB Stockholders Elect Directors, Ratify KPMG, Approve Executive Compensation

5d ago

News Here are the major earnings after the close Monday

27d ago

News Nuvation Bio expects gross-to-net to stabilize around 30% as IBTROZI shifts to >50% TKI-naive starts

28d ago

SEC filing NUVB Reports $18.5M Q1 Revenue, $533.7M Cash, Adds Japan Safusidenib Rights, NCCN Guideline Inclusion

28d ago

Short volume Short volume 69% of volume (4.2σ)

38d ago

Insider trade Sale by Kerry Wentworth (CHIEF REGULATORY OFFICER)

39d ago

Insider trade Sale by Dongfang Liu (CHIEF MEDICAL OFFICER)

39d ago

Insider trade Sale by Dongfang Liu (CHIEF MEDICAL OFFICER)

41d ago

Insider trade Sale by Kerry Wentworth (CHIEF REGULATORY OFFICER)

41d ago

Insider trade Sale by Kerry Wentworth (CHIEF REGULATORY OFFICER)

54d ago

News Nuvation Bio outlines first-line IBTROZI growth strategy with 50-month median DOR amid expanding global partnerships

91d ago

News Nuvation Bio GAAP EPS of -$0.11 misses by $0.02, revenue of $41.9M beats by $4.4M

91d ago

News New Treatment Modalities Are Reaching Cancers That Resisted Everything Else

105d ago

Short volume Short volume 74% of volume (5.8σ)

114d ago

News Nuvation Bio Inc. (NUVB) Price Target Lowered as IBTROZI Sales Meet Expectations

133d ago

News Nuvation Bio Inc. (NUVB) Announces Exclusive Licensing Agreement With Eisai to Expand Global Reach of Taletrectinib

138d ago

News Nuvation Bio says preliminary Q4 and FY25 IBTROZI net product revenue was $15.7M and $24.7M

141d ago

News Nuvation Bio Chief Scientist Sells 100,000 Shares Under Trading Plan — Here's What to Know About the Stock

153d ago